bardoxolone methyl

Reata Bags $350M As It Preps Rare Chronic Kidney Disease Drug For FDA
Xconomy
Thu, 06/11/20 - 10:42 pm
Reata Pharmaceuticals
kidney disease
Alport
chronic kidney disease
bardoxolone methyl
Reata buys drug rights back from AbbVie for $330M before readout
Biopharma Dive
Thu, 10/10/19 - 12:53 pm
Reata Pharmaceuticals
AbbVie
bardoxolone methyl
Reata buoyed by positive data for kidney disease drug
BioPharma Dive
Mon, 11/6/17 - 08:20 pm
Reata Pharmaceuticals
kidney disease
bardoxolone methyl
New Data on Abbott Kidney Drug Candidate
Yahoo/Zacks.com
Tue, 06/28/11 - 11:35 pm
Abbott Laboratories
Shire
Sanofi
bardoxolone methyl
Reata
kidney disease
Abbott Reveals Positive Results From Phase-2 Trial Of Kidney Drug
RTT News
Sat, 06/25/11 - 11:03 am
Abbott Laboratories
bardoxolone methyl
chronic kidney disease